Barriers to early diagnosis, treatment and resources like enabling environments put people living with Advanced HIV Disease (AHD) at greater risk for worsened outcomes. COVID-19 and the resulting disruptions to key supply chains and interventions for those with AHD further complicate the already concerning statistics.
It is estimated that 4 out of 10 HIV-related deaths could be prevented by dealing with AHD. People living with AHD are also at greater risk of contracting opportunistic infections such as tuberculosis and cryptococcal meningitis. Yet why do people continue to die from AHD when diagnostic services and treatment exist?
A new content series produced in partnership between BD and Devex looks at how this can be changed by sharing insights from practitioners, policymakers, and people living with AHD. You can join the conversation using the hashtag #AdvancedHIV.
If you are interested in the content series and would like to learn more, thank you for registering, we will be pleased to send it.
CD4 testing — still the best measurement to identify advanced HIV disease
By Devex - produced in partnership with BD
Despite significant progress in the fight against HIV, approximately one-third of all people living with HIV only present to care by the time the virus has severely weakened their immune systems and they are at an advanced stage of the disease.
Q&A: Tackling advanced HIV disease and stigma in key populations
By Devex - produced in partnership with BD
Access to HIV treatment and care can be particularly difficult for a number of groups such as men who have sex with men, and sex workers. Devex spoke to a former sex worker turned advocate about the challenges facing the LGBTQ community in Malawi.
Opinion: Ensuring services for people with Advanced HIV disease — more important than ever
By Devex - produced in partnership with BD
The global health community is increasingly concerned about COVID-19's impact on the 37.9 million people living with HIV globally. We hear why it's vital that testing and treatment services are available during health crises.
Stopping AHD: Lessons from the ground
Hear from Dr. Stephen Watiti on the importance of treatment literacy for AHD patients. Dr. Watiti is a medical doctor and HIV activist who has been living with HIV since the 1980s. He currently serves as Chairperson of the National Forum for People Living with HIV/AIDS Network in Uganda.
Stopping AHD: Lessons from the ground
Zibusiso Ndlovu discusses the increased need for CD4 testing. Zibusiso is a Laboratory Advisor and Epidemiologist with Médecins Sans Frontières.
Devex
Devex is the media platform for the global development community. A social enterprise, we connect and inform over one million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people.
Becton, Dickinson & Company
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
If you are interested in the content series and would like to learn more, thank you for registering, we will be pleased to send it.
